192 related articles for article (PubMed ID: 37298687)
1. A Targeted Mass Spectrometry Approach to Identify Peripheral Changes in Metabolic Pathways of Patients with Alzheimer's Disease.
Reveglia P; Paolillo C; Angiolillo A; Ferretti G; Angelico R; Sirabella R; Corso G; Matrone C; Di Costanzo A
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298687
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study.
Mahajan UV; Varma VR; Griswold ME; Blackshear CT; An Y; Oommen AM; Varma S; Troncoso JC; Pletnikova O; O'Brien R; Hohman TJ; Legido-Quigley C; Thambisetty M
PLoS Med; 2020 Jan; 17(1):e1003012. PubMed ID: 31978055
[TBL] [Abstract][Full Text] [Related]
3. Unbiased Metabolomic Investigation of Alzheimer's Disease Brain Points to Dysregulation of Mitochondrial Aspartate Metabolism.
Paglia G; Stocchero M; Cacciatore S; Lai S; Angel P; Alam MT; Keller M; Ralser M; Astarita G
J Proteome Res; 2016 Feb; 15(2):608-18. PubMed ID: 26717242
[TBL] [Abstract][Full Text] [Related]
4. Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's disease.
González-Domínguez R; García-Barrera T; Gómez-Ariza JL
J Pharm Biomed Anal; 2015 Mar; 107():75-81. PubMed ID: 25575172
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic study of lipids in serum for biomarker discovery in Alzheimer's disease using direct infusion mass spectrometry.
González-Domínguez R; García-Barrera T; Gómez-Ariza JL
J Pharm Biomed Anal; 2014 Sep; 98():321-6. PubMed ID: 24992214
[TBL] [Abstract][Full Text] [Related]
6. Widely targeted metabolomics of Alzheimer's disease postmortem cerebrospinal fluid based on 9-fluorenylmethyl chloroformate derivatized ultra-high performance liquid chromatography tandem mass spectrometry.
Muguruma Y; Tsutsui H; Noda T; Akatsu H; Inoue K
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1091():53-66. PubMed ID: 29852382
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Hair Metabolome in 5xFAD Mice and Patients with Alzheimer's Disease Using Mass Spectrometry-Based Metabolomics.
Chang CW; Hsu JY; Lo YT; Liu YH; Mee-Inta O; Lee HT; Kuo YM; Liao PC
ACS Chem Neurosci; 2024 Feb; 15(3):527-538. PubMed ID: 38269400
[TBL] [Abstract][Full Text] [Related]
8. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
Varma VR; Oommen AM; Varma S; Casanova R; An Y; Andrews RM; O'Brien R; Pletnikova O; Troncoso JC; Toledo J; Baillie R; Arnold M; Kastenmueller G; Nho K; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R; Legido-Quigley C; Thambisetty M
PLoS Med; 2018 Jan; 15(1):e1002482. PubMed ID: 29370177
[TBL] [Abstract][Full Text] [Related]
9. Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorder.
Xu J; Begley P; Church SJ; Patassini S; Hollywood KA; Jüllig M; Curtis MA; Waldvogel HJ; Faull RL; Unwin RD; Cooper GJ
Biochim Biophys Acta; 2016 Jun; 1862(6):1084-92. PubMed ID: 26957286
[TBL] [Abstract][Full Text] [Related]
10. Application of metabolomics based on direct mass spectrometry analysis for the elucidation of altered metabolic pathways in serum from the APP/PS1 transgenic model of Alzheimer's disease.
González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
J Pharm Biomed Anal; 2015 Mar; 107():378-85. PubMed ID: 25656489
[TBL] [Abstract][Full Text] [Related]
11. Metabolic profiling of Alzheimer's disease: Untargeted metabolomics analysis of plasma samples.
Milos T; Rojo D; Nedic Erjavec G; Konjevod M; Tudor L; Vuic B; Svob Strac D; Uzun S; Mimica N; Kozumplik O; Barbas C; Zarkovic N; Pivac N; Nikolac Perkovic M
Prog Neuropsychopharmacol Biol Psychiatry; 2023 Dec; 127():110830. PubMed ID: 37454721
[TBL] [Abstract][Full Text] [Related]
12. Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease.
González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2395-402. PubMed ID: 25281826
[TBL] [Abstract][Full Text] [Related]
13. Using direct infusion mass spectrometry for serum metabolomics in Alzheimer's disease.
González-Domínguez R; García-Barrera T; Gómez-Ariza JL
Anal Bioanal Chem; 2014 Nov; 406(28):7137-48. PubMed ID: 25230597
[TBL] [Abstract][Full Text] [Related]
14. Brain and blood metabolome for Alzheimer's dementia: findings from a targeted metabolomics analysis.
Huo Z; Yu L; Yang J; Zhu Y; Bennett DA; Zhao J
Neurobiol Aging; 2020 Feb; 86():123-133. PubMed ID: 31785839
[TBL] [Abstract][Full Text] [Related]
15. A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.
Yilmaz A; Ustun I; Ugur Z; Akyol S; Hu WT; Fiandaca MS; Mapstone M; Federoff H; Maddens M; Graham SF
J Alzheimers Dis; 2020; 78(4):1381-1392. PubMed ID: 33164929
[TBL] [Abstract][Full Text] [Related]
16. High-Throughput Metabolomics for Discovering Potential Metabolite Biomarkers and Metabolic Mechanism from the APPswe/PS1dE9 Transgenic Model of Alzheimer's Disease.
Yu J; Kong L; Zhang A; Han Y; Liu Z; Sun H; Liu L; Wang X
J Proteome Res; 2017 Sep; 16(9):3219-3228. PubMed ID: 28753016
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Alterations in the Outer Membrane Vesicles of Patients with Alzheimer's Disease: An LC-MS/MS-based Metabolomics Analysis.
Wei SC; Wei W; Peng WJ; Liu Z; Cai ZY; Zhao B
Curr Alzheimer Res; 2019; 16(13):1183-1195. PubMed ID: 31755388
[TBL] [Abstract][Full Text] [Related]
18. Disturbed microbial ecology in Alzheimer's disease: evidence from the gut microbiota and fecal metabolome.
Xi J; Ding D; Zhu H; Wang R; Su F; Wu W; Xiao Z; Liang X; Zhao Q; Hong Z; Fu H; Xiao Q
BMC Microbiol; 2021 Aug; 21(1):226. PubMed ID: 34384375
[TBL] [Abstract][Full Text] [Related]
19. Serum Metabolomic and Lipidomic Profiling Reveals Novel Biomarkers of Efficacy for Benfotiamine in Alzheimer's Disease.
Bhawal R; Fu Q; Anderson ET; Gibson GE; Zhang S
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947984
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
